Zeevalk GD[au] - Search Results

Year	Number of Results
1982	1
1984	1
1986	2
1987	1
1988	2
1989	2
1990	2
1991	2
1992	4
1993	2
1994	2
1995	3
1996	4
1997	5
1998	4
2000	4
2001	3
2002	3
2003	2
2004	1
2005	3
2006	3
2007	2
2008	3
2009	1
2010	1
2011	1
2022	0

1

Chronic intraventricular administration of 1-methyl-4-phenylpyridinium as a progressive model of Parkinson's disease.

Sonsalla PK, Zeevalk GD, German DC. Sonsalla PK, et al. Among authors: zeevalk gd. Parkinsonism Relat Disord. 2008;14 Suppl 2(Suppl 2):S116-8. doi: 10.1016/j.parkreldis.2008.04.008. Epub 2008 Jun 25. Parkinsonism Relat Disord. 2008. PMID: 18583172 Free PMC article. Review.

2

Mitochondrial inhibition and oxidative stress: reciprocating players in neurodegeneration.

Zeevalk GD, Bernard LP, Song C, Gluck M, Ehrhart J. Zeevalk GD, et al. Antioxid Redox Signal. 2005 Sep-Oct;7(9-10):1117-39. doi: 10.1089/ars.2005.7.1117. Antioxid Redox Signal. 2005. PMID: 16115016 Review.

3

NMDA receptor involvement in two animal models of Parkinson's disease.

Zeevalk GD, Nicklas WJ, Sonsalla PK. Zeevalk GD, et al. Neurobiol Aging. 1994 Mar-Apr;15(2):269-70. doi: 10.1016/0197-4580(94)90130-9. Neurobiol Aging. 1994. PMID: 7838309 Review. No abstract available.

4

Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism.

Sonsalla PK, Albers DS, Zeevalk GD. Sonsalla PK, et al. Among authors: zeevalk gd. Amino Acids. 1998;14(1-3):69-74. doi: 10.1007/BF01345245. Amino Acids. 1998. PMID: 9871444 Review.

5

Hypothermia, metabolic stress, and NMDA-mediated excitotoxicity.

Zeevalk GD, Nicklas WJ. Zeevalk GD, et al. J Neurochem. 1993 Oct;61(4):1445-53. doi: 10.1111/j.1471-4159.1993.tb13639.x. J Neurochem. 1993. PMID: 8376998

6

Glutathione and Parkinson's disease: is this the elephant in the room?

Zeevalk GD, Razmpour R, Bernard LP. Zeevalk GD, et al. Biomed Pharmacother. 2008 Apr-May;62(4):236-49. doi: 10.1016/j.biopha.2008.01.017. Epub 2008 Mar 14. Biomed Pharmacother. 2008. PMID: 18400456

7

Liposomal-glutathione provides maintenance of intracellular glutathione and neuroprotection in mesencephalic neuronal cells.

Zeevalk GD, Bernard LP, Guilford FT. Zeevalk GD, et al. Neurochem Res. 2010 Oct;35(10):1575-87. doi: 10.1007/s11064-010-0217-0. Epub 2010 Jun 10. Neurochem Res. 2010. PMID: 20535554

8

Characterization of reduced and oxidized dopamine and 3,4-dihydrophenylacetic acid, on brain mitochondrial electron transport chain activities.

Gautam AH, Zeevalk GD. Gautam AH, et al. Among authors: zeevalk gd. Biochim Biophys Acta. 2011 Jul;1807(7):819-28. doi: 10.1016/j.bbabio.2011.03.013. Epub 2011 Apr 2. Biochim Biophys Acta. 2011. PMID: 21463600 Free PMC article.

9

Rat model of Parkinson's disease: chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+).

Yazdani U, German DC, Liang CL, Manzino L, Sonsalla PK, Zeevalk GD. Yazdani U, et al. Among authors: zeevalk gd. Exp Neurol. 2006 Jul;200(1):172-83. doi: 10.1016/j.expneurol.2006.02.002. Epub 2006 Mar 20. Exp Neurol. 2006. PMID: 16546169

10

Excitotoxicity and oxidative stress during inhibition of energy metabolism.

Zeevalk GD, Bernard LP, Sinha C, Ehrhart J, Nicklas WJ. Zeevalk GD, et al. Dev Neurosci. 1998;20(4-5):444-53. doi: 10.1159/000017342. Dev Neurosci. 1998. PMID: 9778583

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results